A practical reference on Peptide storage: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-11-03 and is reviewed periodically as new material appears.
Identity and purity are checked by reversed-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, where the peptide bond absorbs. Mass spectrometry confirms the expected mass and reveals whether truncation products or adducts are present. Acid hydrolysis followed by amino acid analysis gives the residue ratio, which should approximate one alanine, one glutamate, one aspartate and one glycine. Counter-ions such as acetate or trifluoroacetate remain in the dried product and lower net peptide content, so a stated purity figure on a label does not by itself describe how much peptide a vial holds.
Regulatory treatment differs by country. No formulation of epitalon holds a marketing authorisation as a medicine in the United States or the European Union, where material sold for laboratory use is handled as a research chemical and is not intended for human consumption. In Russia, several short peptide preparations from the same institute's peptide series are registered medicinal products, and epitalon appears in that national context. Elsewhere it is frequently offered as a cosmetic ingredient, a category with lighter requirements. Advertising claims about longevity or disease prevention are restricted in most jurisdictions, which limits how sellers describe the compound.
Identity and purity are established with reversed-phase high-performance liquid chromatography and mass spectrometry. The chromatogram shows the main peak and any truncated or oxidised by-products, while the mass spectrum confirms the expected 390 dalton mass. Amino acid analysis can corroborate composition when a sample's origin is uncertain. Counterion content, particularly residual trifluoroacetate from purification, is frequently reported alongside purity because it shifts the net mass of the solid.
Reference material is normally supplied as a lyophilised powder in a sealed vial. Product literature typically recommends storage at minus twenty degrees Celsius or colder, protected from light and moisture. Freeze-thaw cycling is usually avoided because repeated condensation can introduce water into the vial. Working solutions are commonly prepared fresh, aliquoted, and kept cold for short periods rather than stored at ambient temperature. Labelling the date of opening helps track how long a vial has been in use.
Solubility is high in water, phosphate-buffered saline and normal saline, a pattern that follows from the two acidic residues in the chain. The peptide dissolves poorly in non-polar solvents such as hexane or chloroform. Stock solutions are often prepared in water first and then diluted into the buffer of interest. Because the molecule is small and hydrophilic, filtration through a low-protein-binding membrane is usually straightforward, and visible particulates are uncommon in freshly made solutions.
| Property | Value | Notes |
|---|---|---|
| Storage temperature, solid | Approximately -20 C | Sealed, desiccated, protected from light |
| Typical identity method | Electrospray mass spectrometry | Protonated ion expected near 391 |
| Typical purity method | Reversed-phase HPLC | Ultraviolet detection near 214 nm |
| Common synonyms | Epithalon, epithalone, AEDG | Spelling variants appear in supplier catalogues |
| Solution stability | Days at 2-8 C | Hydrolysis and deamidation limit shelf life |
Epitalon appears in the literature primarily through a small number of research groups, most of them associated with the St. Petersburg Institute of Bioregulation and Gerontology. Publications describe cell culture experiments, animal studies, and a limited number of small human studies. Independent replication outside this network is sparse. As a result, reviews of the topic usually separate descriptive reports of observed effects from the question of whether those effects generalize, and they note the difficulty of comparing studies that use different preparations and endpoints.
Analytical characterization of epitalon relies on standard peptide methods. Reverse-phase high-performance liquid chromatography is used to assess purity, and mass spectrometry confirms identity by checking the observed mass against the expected value near 390 daltons. Amino acid analysis can verify composition. Because the peptide is short and hydrophilic, it elutes early on many reverse-phase columns, so method development often requires ion-pairing reagents to achieve adequate retention and resolution from related impurities.
Purity assessment of peptide reagents normally relies on reversed-phase high-performance liquid chromatography. A gradient of acetonitrile in water with trifluoroacetic acid, paired with a C18 stationary phase, separates the target tetrapeptide from truncated sequences and deletion analogues. Detection at 214 nanometres exploits absorbance of the peptide backbone, since the molecule contains no aromatic residue. Results are expressed as a percentage of total peak area. Values above ninety-five percent are typical for research-grade material, although reporting conventions vary between suppliers.
Identity confirmation uses mass spectrometry, usually electrospray ionisation in positive mode or matrix-assisted laser desorption. The protonated free peptide produces a signal near three hundred and ninety-one daltons, while salt adducts shift that value slightly. Tandem mass spectrometry or amino acid analysis supplies sequence-level confirmation, which a single mass measurement cannot. Peptides containing aspartate can cyclise into succinimide intermediates that hydrolyse to isoaspartate isomers of identical mass. Because those isomers are difficult to separate chromatographically, identity and purity results carry more weight when interpreted together.
Storage practice centres on limiting moisture, oxygen, and repeated temperature cycling. Freeze-dried powder is generally held desiccated at minus twenty degrees Celsius or colder and protected from light. Reconstituted solutions are markedly less stable, and the aspartate-glycine junction is prone to succinimide formation at neutral to mildly alkaline pH. Portioning material into single-use aliquots reduces degradation compared with repeated freeze-thaw cycles. Stability data specific to this tetrapeptide remain scarce, so most handling guidance is extrapolated from general peptide chemistry rather than measured directly.
To ensure highly anisotropic, yet predictable solidification behavior within the SSZ, dynamic freezing patterns are preferred. Using dynamic freezing, the velocity of the solidification front, and, therefore, the ice crystal size, can be controlled with a changing temperature gradient. The increasing thermal gradient counters the effect of the growing thermal buffer imposed by the growing ice front. It has been shown that a linearly decreasing temperature on one side of a freeze-cast will result in near-constant solidification velocity, yielding ice crystals with an almost constant thickness along the SSZ of an entire sample. However, as pointed out by Waschkies et al. even with constant solidification velocity, the thickness of the ice crystals does increase slightly over the course of freezing. In contrast to that, Flauder et al. demonstrated that an exponential change of the temperature at the cooling plate leads to a constant ice crystal thickness within the complete SSZ, which was attributed to a measurably constant ice-front velocity in a distinct study. This approach enables a prediction of the ice-front velocity from the thermal parameters of the suspension. Consequently, if the exact relationship between the pore diameter and ice-front velocity is known, an exact control over the pore diameter can be achieved.
=== Quartz fiber filter === Quartz fiber filter paper has a high resistance to chemicals, does not absorb NOx and SOx dioxides, is unaffected by humidity and is easily sterilized. Thus, it is mostly used for air pollution analysis.
They bury their dead with their heads directly downward, because they hold an opinion, that in eleven thousand moons they are all to rise again; in which period the earth (which they conceive to be flat) will turn upside down, and by this means they shall, at their resurrection, be found ready standing on their feet. The learnèd among them confess the absurdity of this doctrine; but the practice still continues, in compliance to the vulgar. Swift's notion of inverted burial might seem the highest flight of fancy, but it appears that among English millenarians the idea that the world would be "turned upside down" at the Apocalypse enjoyed some currency. There is at least one attested case of a person being buried upside down by instruction; a Major Peter Labilliere of Dorking (d. 4 June 1800) lies thus upon the summit of Box Hill. Similar stories have attached themselves to other noted eccentrics, particularly in southern England, but not always with a foundation in truth.
==== Capillary electrophoresis ==== Capillary electrophoresis (CE)is emerging as the preferred analytical method for YTX analysis, as it has significant advantages over the other analytical techniques used, including high efficiency, a fast and simple separation procedure, a small sample volume required, and minimal reagent is required. The techniques used for YTX analysis include: CE with ultraviolet (UV) detection and CE coupled to mass spectrometry (MS). CEUV is a good method for YTX analysis, as its selectivity can easily differentiate between YTXs and DSP toxins. The sensitivity of these techniques can, however, be poor due to the low molar absorptivity of the analytes. The technique gives a limit of detection (LOD) of 0.3 μg/ml and a limit of quantification (LOQ)of 0.9 μg/ml. The sensitivity of conventional CEUV can be improved by using micellar electrokinetic chromatography (MEKC). CEMS has the added advantage over CEUV of being able to give molecular weight and/or structural information about the analyte. This enables the user to carry out unequivocal confirmations of the analytes present in the sample. The LOD and the LOQ have been calculated as 0.02 μg/ml and 0.08 μg/ml, respectively, again meeting the European Commission directive.
=== Cation-exchange resin === Formula: R−H acidic The cation exchange method removes the hardness of water but induces acidity in it, which is further removed in the next stage of treatment of water by passing this acidic water through an anion exchange process. Reaction:
Sources: en.wikipedia.org
Through hundreds of photographs, she demonstrates that the image of a female displaying her vulva is not specific to European religious art or architecture, but that similar images are found in the visual arts and in mythical narratives of goddesses and heroines parting their thighs to reveal what she calls, "sacred powers". Her theory is that "the image is so rooted in our psyches that it seems as if the icon is the original cosmological center of the human imagination".
252.01 Hyperparathyroidism, primary 252.1 Hypoparathyroidism 253 Disorders of the pituitary gland and its hypothalamic control 253.3 Growth hormone deficiency 253.6 SIADH 254 Diseases of thymus gland 255 Disorders of adrenal glands 255.0 Cushing's syndrome 256 Ovarian dysfunction 256.2 Ovarian failure, postablative 256.39 Ovarian failure, other 256.4 Ovaries, polycystic 257 Testicular dysfunction 257.2 Testicular hypofunction 258 Polyglandular dysfunction and related disorders 259 Other endocrine disorders 259.0 Puberty, delayed 259.1 Sexual precocity
Valves in the perforating veins close when a calf muscle contracts, to prevent backflow from the deep veins to the superficial. There are more valves in the lower leg, due to increased gravitational pull, with the number decreasing as the veins travel to the hip. There are no valves in the veins of the thorax or abdomen. There is a valve at the junction of the inferior vena cava (one of the great vessels) and the right atrium known as the valve of inferior vena cava also known as the eustachian valve. This valve is an embryological remnant and is insignificant in the adult. However, when persistent it can cause problems.
Chevreul was born in the town of Angers, France, where his father was a physician. Chevreul's birth certificate, kept in the registry book of Angers, bears the signature of his father, grandfather, and a great-uncle, all of whom were surgeons. At around the age of seventeen, Chevreul went to Paris and entered L. N. Vauquelin's chemical laboratory, afterwards becoming his assistant at the Muséum national d'histoire naturelle (National Museum of Natural History) in the Jardin des Plantes. In 1813, Chevreul was appointed professor of chemistry at the Lycée Charlemagne, and subsequently undertook the directorship of the Gobelins tapestry works, where he carried out his research on colour contrasts. (In 1839, he published the results of his research under the title De la loi du contraste simultané des couleurs; It was translated into English and published in 1854 under the title The Principles of Harmony and Contrast of Colors. A new translation titled On the Law of Simultaneous Contrast of Colors, with commentary, additional chapters, and colour graphics by Dan Margulis, appeared in 2020.) In 1826, Chevreul became a member of the Academy of Sciences, and in the same year was elected a foreign member of the Royal Society of London, whose Copley Medal he was awarded in 1857. In 1829, he was elected a foreign member of the Royal Swedish Academy of Sciences and a Foreign Honorary Member of the American Academy of Arts and Sciences in 1868.
== Method == SISCAPA is an extension of the well-known gold-standard methods of stable-isotope dilution for quantitation of small molecules by mass spectrometry (MS). Rather than measure an intact protein directly by mass spectrometry, SISCAPA makes use of proteolytic digestion (e.g., with the enzyme trypsin) to cleave sample proteins into smaller peptides ideally suited to quantitation by mass spectrometry. By selecting a target peptide whose sequence occurs only in the selected target protein (a so-called “proteotypic” peptide), the target peptide can serve as a direct quantitative surrogate for the target protein (assuming the digestion process is complete, or at least reproducible). A synthetic version of the target peptide containing a stable isotope label is added in a known amount to the digested sample to serve as an internal standard (SIS). Since the target peptide and SIS are chemically indistinguishable throughout the workflow, but can be measured separately by a mass spectrometer due to the mass difference of the stable isotope label, their ratio provides the desired quantitative estimate of the target peptide amount. The SISCAPA workflow adds a specific enrichment step to the isotope dilution method in which a selected target peptide, together with its associated SIS internal standard, is captured by a sequence-specific anti-peptide antibody.
Sources: en.wikipedia.org
The solid is kept cold, dry and dark, typically at minus twenty degrees Celsius, in a sealed container with desiccant. Dissolved material is kept refrigerated and used promptly. Freezing and thawing a solution repeatedly is avoided because it accelerates degradation.
Reversed-phase chromatography with ultraviolet detection gives a purity percentage, while mass spectrometry confirms identity. Amino acid analysis checks the residue composition. Buyers typically request a certificate of analysis showing these measurements for the specific lot.
It is not authorised as a medicine in the United States or the European Union. Material is sold there as a research chemical or cosmetic ingredient. Some related short peptides are registered drugs in Russia, which is a distinct national situation rather than a general approval.
Sealed lyophilised powder is normally kept at minus twenty degrees Celsius or below, away from light and moisture. Vials are allowed to reach room temperature before opening to limit condensation. Repeated warming and cooling of the same vial is discouraged.